Ata uhi

Study of cardiovascular eligibility for hormonal contraception in women in Porto-Novo

<p>Introduction: The aim of this study was to determine the cardiovascular eligibility rate for hormonal contraception among women in Porto-Novo, with reference to the criteria defined by the World Health Organization (WHO).</p><p>Materials and methods: A descriptive cross-sectiona...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Arnaud Sonou (Author), Richard Aniglé (Author), Corine Houehanou (Author), Armand Wanvoègbè (Author), Mathieu Ogoudjobi (Author), Dèdonougbo Martin Houénassi (Author)
Hōputu:	Pukapuka
I whakaputaina:	Archives of Clinical Hypertension - Peertechz Publications, 2020-04-24.
Ngā marau:	Research Article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Medical eligibility criteria for contraceptive use
mā: Ma. del Carmen Cravioto Galindo
I whakaputaina: (2016)

The paradigm for cardiovascular effects of hormonal contraceptives
mā: Zsuzsanna Ilona Katalin de Jármy Di Bella
I whakaputaina: (2018)

Feasibility of a cardiovascular cohort in a Sub-Saharan Africa community: preliminary report of the pilot project TAHES (Tanvè Health Study) in Benin
mā: Yessito Corine Houehanou, me ētahi atu.
I whakaputaina: (2017)

Medical eligibility criteria for using various methods of contraception
mā: V N Prilepskaya, me ētahi atu.
I whakaputaina: (2014)

Acceptability of Contraceptive Methods among Urban Eligible Couples of Imphal, Manipur
mā: Singh RK, me ētahi atu.
I whakaputaina: (2004)

New contraceptive eligibility checklists for provision of combined oral contraceptives and depot-medroxyprogesterone acetate in community-based programmes
mā: Amanda Stang, me ētahi atu.
I whakaputaina: (2000)

Uso seguro de anticoncepcionais hormonais injetáveis segundo critérios médicos de elegibilidade / Safe use of injectable hormonal contraceptives according to medical eligibility criteria
mā: Ana Gesselena da Silva Farias, me ētahi atu.
I whakaputaina: (2018)

Uso seguro de anticoncepcionais hormonais injetáveis segundo critérios médicos de elegibilidade / Safe use of injectable hormonal contraceptives according to medical eligibility criteria
mā: Ana Gesselena da Silva Farias, me ētahi atu.
I whakaputaina: (2018)

Uso seguro de anticoncepcionais hormonais injetáveis segundo critérios médicos de elegibilidade / Safe use of injectable hormonal contraceptives according to medical eligibility criteria
mā: Ana Gesselena da Silva Farias, me ētahi atu.
I whakaputaina: (2018)

Uso seguro de anticoncepcionais hormonais injetáveis segundo critérios médicos de elegibilidade / Safe use of injectable hormonal contraceptives according to medical eligibility criteria
mā: Ana Gesselena da Silva Farias, me ētahi atu.
I whakaputaina: (2018)

Contraceptive Practices among the Eligible Couples from a Rural and an Urban Area of Karnataka
mā: Niranjan V Gummaraj, me ētahi atu.
I whakaputaina: (2018)

Disparities in effective contraceptive use in the United States among individuals dually eligible for Medicare and Medicaid
mā: Maria I. Rodriguez, MD, MPH, me ētahi atu.
I whakaputaina: (2023)

Medical sequencing of de novo ectodermal dysplasia in identical twins and evaluation of the potential eligibility for recombinant EDA therapy
mā: Adriana Modesto, me ētahi atu.
I whakaputaina: (2017)

Modern hormonal contraceptives
mā: -
I whakaputaina: (2017)

Personification of hormonal contraception
mā: L Yu Karakhalis, me ētahi atu.
I whakaputaina: (2016)

Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives?
mā: Fruzzetti F, me ētahi atu.
I whakaputaina: (2018)

National medical eligibility criteria for contraceptive use 2023: focus on women's reproductive health: A review
mā: Elena N. Andreeva, me ētahi atu.
I whakaputaina: (2023)

Effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a Ghanaian community
mā: Asare GA, me ētahi atu.
I whakaputaina: (2014)

Personal selection of hormonal contraception
mā: I V Kuznetsova
I whakaputaina: (2017)

Personified choice of hormonal contraception
mā: L Yu Karakhalis
I whakaputaina: (2018)

COVID-19 and hormonal contraception
mā: Angelo Cagnacci, me ētahi atu.
I whakaputaina: (2022)

Hormonal contraception: choice algorithm
mā: A.A. Olina, me ētahi atu.
I whakaputaina: (2019)

Cross-Sectional Analyses of Social Determinants of Contraceptive Use among Eligible Couples, Rural Ujjain, Madhya Pradesh
mā: Shikha Sharma, me ētahi atu.
I whakaputaina: (2017)

Emergency hormonal contraception (literature review)
mā: V N Prilepskaya, me ētahi atu.
I whakaputaina: (2017)

Use of outpatient care in VA and Medicare among disability-eligible and age-eligible veteran patients
mā: Liu Chuan-Fen, me ētahi atu.
I whakaputaina: (2012)

Pharmacist-Prescribed Hormonal Contraception: Does Didactic Hormonal Contraception Education Affect Student Pharmacist Perceptions of This Professional Activity?
mā: Rachel Rikard, me ētahi atu.
I whakaputaina: (2021)

Estudo de Mercado sobre a Aceitação de um Novo Sabonete de Vinho do Porto
mā: Raquel Guiné, me ētahi atu.
I whakaputaina: (2016)

Important questions to ask when choosing hormonal contraception. Myths about contraception
mā: Vera N. Prilepskaya, me ētahi atu.
I whakaputaina: (2021)

Hormonal Contraceptive Use in Football Codes in Australia
mā: Anthea C. Clarke, me ētahi atu.
I whakaputaina: (2021)

Prolonged schemes of combined hormonal contraceptives assignment
mā: V V Korennaya, me ētahi atu.
I whakaputaina: (2015)

Hormonal contraception with desogestrel-induced medication use
mā: S A Levakov, me ētahi atu.
I whakaputaina: (2014)

Needs, expectations and doubt users of hormonal contraceptives
mā: Galina B. Dikke
I whakaputaina: (2020)

Female sexual function and hormonal contraception (review)
mā: N N Stenyaeva, me ētahi atu.
I whakaputaina: (2013)

Clinical Pharmacology of Hormonal Emergency Contraceptive Pills
mā: Celia M. J. Matyanga, me ētahi atu.
I whakaputaina: (2018)

The Potential of Hormonal Contraception to Influence Female Sexuality
mā: Filipa de Castro Coelho, me ētahi atu.
I whakaputaina: (2019)

Hormonal contraception in terms of effect on the hemostasis system
mā: E.G. Kudinova
I whakaputaina: (2023)

Market Diffusion of Extended Cycle Hormonal Contraceptives
mā: Megen Leeds Schumacher, me ētahi atu.
I whakaputaina: (2012)

Positif Correlation of Hormonal Contraception and The Occurrence of Leucorrhoea
mā: Mirza Aulia Cahyani, me ētahi atu.
I whakaputaina: (2023)

Market Diffusion of Extended Cycle Hormonal Contraceptives
mā: Megen Leeds Schumacher, Pharm.D, me ētahi atu.
I whakaputaina: (2012)

Drafting eligible biotech and immunotherapy claims
mā: Shyh-Jen Wang
I whakaputaina: (2019)